TCL Archive DCT Board Approves New Task Orders For RMP Clinical Trials, Holds Up On Additional Grants February 20, 1981
TCL Archive NCI, NIH Make Half-Hearted Pitch For Cancer Act Before Seemingly Uninterested Rogers Committee March 10, 1978
TCL Archive National Cancer Policy Board calls for public-private partnership for R&D in pediatric cancer drugs. April 22, 2005
TCL Archive Two Conflicting Studies Presented at ASCO 2013, FDA Called Upon To Sort Through The Data June 28, 2013
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
